UCL Innovative Clinical Trials Unit highlighted results from the ARCHERY study exploring AI in radiotherapy planning pathways in low- and middle-income countries.

The UCL Innovative Clinical Trials Unit (formerly the MRC Clinical Trials Unit at UCL) is at the forefront of resolving internationally important questions in infectious diseases, cancer and neurodegenerative diseases, and delivering swifter and more effective translation of scientific research into patient benefits. We do this by designing and conducting innovative clinical trials, and developing methodological advances in study design, conduct and analysis. We also carry out observational studies to evaluate the impact of new interventions in routine care. Our research helps to improve healthcare in the UK and around the world. Smarter studies. Global impact. Better health.